Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K

被引：15
|
作者：
Barrett, DG
Catalano, JG
Deaton, DN [1 ]
Long, ST
Miller, LR
Tavares, FX
Wells-Knecht, KJ
Wright, LL
Zhou, HQQ
机构：
[1] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Discovery Res Biol, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Res Bioanal & Drug Metab, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline, Dept Mol Pharmacol, Res Triangle Pk, NC 27709 USA
[5] GlaxoSmithKline, Dept World Wide Phys Properties, Res Triangle Pk, NC 27709 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 10期
关键词：
cathepsin K; ketoamide; cysteine protease inhibitors;
D O I：
10.1016/j.bmcl.2004.02.085
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
An orally available series of ketoamide-based inhibitors of cathepsin K has been identified. Starting from a potent inhibitor with poor oral bioavailability, modifications to P-1 and P-1' elements led to enhancements in solubility and permeability. These improvements resulted in orally available cathepsin K inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2543 / 2546
页数：4
相关论文
共 50 条
  • [1] Design of small molecule ketoamide-based inhibitors of cathepsin K
    Catalano, JG
    Deaton, DN
    Long, ST
    McFadyen, RB
    Miller, LR
    Payne, JA
    Wells-Knecht, KJ
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) : 719 - 722
  • [2] A structural screening approach to ketoamide-based inhibitors of cathepsin K
    Barrett, DG
    Catalano, JG
    Deaton, DN
    Long, ST
    McFadyen, RB
    Miller, AB
    Miller, LR
    Wells-Knecht, KJ
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2209 - 2213
  • [3] Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K
    Tavares, FX
    Deaton, DN
    Miller, AB
    Miller, LR
    Wright, LL
    Zhou, HQ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) : 5049 - 5056
  • [4] Ketoamide-based inhibitors of cysteine protease, cathepsin K: P3 modifications
    Tavares, FX
    Deaton, DN
    Miller, LR
    Wright, LL
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) : 5057 - 5068
  • [5] Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors
    Cai, Jiaqiang
    Robinson, John
    Belshaw, Simone
    Everett, Kathryn
    Fradera, Xavier
    van Zeeland, Mario
    van Berkom, Leon
    van Rijnsbergen, Peter
    Popplestone, Lucy
    Baugh, Mark
    Dempster, Maureen
    Bruin, John
    Hamilton, William
    Kinghorn, Emma
    Westwood, Paul
    Kerr, Jennifer
    Rankovic, Zoran
    Arbuckle, Wullie
    Bennett, D. Jonathan
    Jones, Philip S.
    Long, Clive
    Martin, Iain
    Uitdehaag, Joost C. M.
    Meulemans, Tommi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6890 - 6894
  • [6] P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K
    Barrett, DG
    Boncek, VM
    Catalano, JG
    Deaton, DN
    Hassell, AM
    Jurgensen, CH
    Long, ST
    McFadyen, RB
    Miller, AB
    Miller, LR
    Payne, JA
    Ray, JA
    Samano, V
    Shewchuk, LM
    Tavares, FX
    Wells-Knecht, KJ
    Willard, DH
    Wright, LL
    Zhou, HQQ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (15) : 3540 - 3546
  • [7] Acyclic, orally bioavailable ketone-based cathepsin K inhibitors
    Barrett, David G.
    Catalano, John G.
    Deaton, David N.
    Long, Stacey T.
    McFadyen, Robert B.
    Miller, Aaron B.
    Miller, Larry R.
    Samano, Vicente
    Tavares, Francis X.
    Wells-Knecht, Kevin J.
    Wright, Lois L.
    Zhou, Hui-Qlang Q.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) : 22 - 27
  • [8] Orally Bioavailable Cathepsin K Inhibitors with Pyrrolopyrimidine Scaffold
    Teno, Naoki
    Masuya, Keiichi
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 752 - 766
  • [9] Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors
    Barrett, DG
    Catalano, JG
    Deaton, DN
    Hassell, AM
    Long, ST
    Miller, AB
    Miller, LR
    Ray, JA
    Samano, V
    Shewchuk, LM
    Wells-Knecht, KJ
    Willard, DH
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1735 - 1739
  • [10] Structure-based design of orally bioavailable cathepsin K inhibitors.
    Thompson, SK
    Michaud, E
    Halbert, SM
    Tomaszek, TA
    Tew, DG
    Zhao, BG
    Smith, WW
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Kurdyla, J
    Jones, CS
    Abdel-Meguid, SS
    Ijames, CF
    DesJarlais, RL
    Salyers, KL
    Smith, BR
    Levy, MA
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1157 - U1157
12345